Newsfeeds - Spark Newswire

1 minute read

Relmada Therapeutics Q2 EPS $(1.56) Misses $(1.47) Estimate

Today, 4:09 AM

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(1.47) by 6.12 percent. This is a 113.7 percent decrease over losses of $(0.73) per share

RLMD

5 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:09 AM

Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows.

ACAD

6 minute read

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts

By Shanthi Rexaline

Today, 4:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9)

ACET

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 4:09 AM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

5 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 4:09 AM

Before 10 a.m. ET Monday, 63 stocks made new 52-week lows.

ACET

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 4:09 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

9 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:09 AM

Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.

ABCL

6 minute read

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs

By Shanthi Rexaline

Today, 4:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)

ACOR

1 minute read

Relmada Therapeutics In-Licenses Psilocybin Program From Arbormentis

By Vandana Singh

Today, 4:09 AM

Relmada Therapeutics Inc (NASDAQ:RLMD) has acquired the development and commercial rights to novel psilocybin and derivate program from Arbormentis LLC in all ex-Asia…

RLMD

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 4:09 AM

ALDX